Elevance Health Stock News

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2025 financial results on October 21, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888...

Elevance Health is significantly undervalued, trading at a 41% discount to industry peers, despite strong revenue growth and a 2.11% dividend yield. ELV's recent selloff was triggered by bottom-line contraction and lowered FY2025 EPS guidance, but revenue growth remains robust, especially in its Carelon segment. Despite margin pressures from rising Medicaid and ACA costs, ELV maintains strong p...

INDIANAPOLIS--(BUSINESS WIRE)--Indianapolis Public Schools' Northwest Middle School today celebrated the unveiling of its newly transformed weight room, a project made possible through a partnership with Elevance Health and the Impact Fitness Foundation (IFF). The initiative is part of Elevance Health's ongoing commitment to the whole health of communities and is the fourth fitness space upgrad...

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health Inc.'s (Elevance Health) (headquartered in Indianapolis, IN) newly issued senior unsecured notes of $750 million, 4.0% senior unsecured notes, due 2028; $750 million, 4.6% senior unsecured notes, due 2032; $1 billion, 5.0% senior unsecured notes, due 2036; and $5...

Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in  Elevance between April 18, 2024, and October 16, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner  Brandon Walker or Marion Passmore directly at (212)...

ELV stands out as an outperformer due to strong historical performance, capital returns, and a robust balance sheet. Sector tailwinds and AI-driven efficiency gains present attractive long-term opportunities, while ELV trades at a comparatively low valuation. Key risks include unpredictable medical costs that could continue outpacing premium revenue growth, potentially offsetting AI benefits, t...

INDIANAPOLIS--(BUSINESS WIRE)--The Elevance Health Foundation has awarded 29 new grants totaling more than $6.5 million to support maternal and infant health programs across the country. The funding will drive innovative, scalable solutions spanning pre-conception care, pregnancy, delivery, postpartum, and infant health, with a focus on reducing disparities and improving outcomes. This latest r...

My Top 15 high-growth dividend stocks for September 2025 are collectively 32% undervalued and offer a 1.43% yield with 21.57% five-year dividend growth. The strategy's five-year annualized return is 11.22%, just shy of my 12% target, but it continues to outperform VIG and SPY year-to-date. Rotation in the list brings in DICK'S Sporting Goods, Elevance Health, Intuit, and Marsh & McLennan, repla...